Stocks & AI: what moved, and why Inspired by zlio.com

HALO Halozyme Therapeutics, Inc.

Nasdaq · Healthcare

HALO chart by TradingView

Tue, Nov 10 0.9× volume +0.1%
Mon, Nov 9 1.2× volume -0.7%
Fri, Nov 6 2.8× volume -15.7%
Thu, Nov 5 1.3× volume -5.7%
Wed, Nov 4 0.7× volume +1.3%
Tue, Nov 3 0.6× volume -0.3%
Mon, Nov 2 1.4× volume -1.5%

Top holding of FHH.TO 2.3%, LABU 0.4%, SCHA 0.3%

News this week

  1. Halozyme expects $1.86B-$1.925B 2026 revenue while raising non-GAAP EPS to $8.75-$9.05
    HALO +0.1%3 sourcesSeeking Alpha ·
  2. Halozyme Reaffirms It Projects Zero to Minimal Impact to Royalty Revenue Through At Least 2035 Based on Medicare Drug Price Negotiation Program Final Rule for IPAY 2029
    HALO +0.1%PR Newswire ·
  3. J&J gains approval of Rybrevant Faspro for head and neck cancer
    HALO +0.1% JNJ -0.5%3 sourcesSeeking Alpha ·